Conventional markers in determination of activity of sarcoidosis
- 1 March 2015
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 25 (1) , 174-179
Abstract
No abstract availableKeywords
Funding Information
- Turkish Respiratory Society (1.06.207/10)
This publication has 21 references indexed in Scilit:
- Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patientsRespiratory Research, 2013
- Total serum IgE levels and atopic status in patients with sarcoidosisAllergy and Asthma Proceedings, 2012
- Comparative Evaluation of Serum Markers in Pulmonary SarcoidosisChest, 2010
- The clinical significance of interleukin 18 assessment in sarcoidosis patientsRespiratory Medicine, 2007
- Serum amyloid A (SAA) in induced sputum of asthmatics: A new look to an old markerInternational Immunopharmacology, 2006
- Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosisCytokine, 2005
- Increased serum YKL-40 in patients with pulmonary sarcoidosis—a potential marker of disease activity?Respiratory Medicine, 2005
- Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in SarcoidosisClinical Chemistry, 2003
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999
- Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993European Respiratory Journal, 1994